Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2018;8(3): 355-363. doi: 10.15171/apb.2018.042
PMID: 30276131        PMCID: PMC6156475

Review Article

A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals

Arun Kumar 1 ORCID, Sandeep Kumar 1 ORCID, Arun Nanda 1 * ORCID

Cited by CrossRef: 50

1- Stevens J. Colorful 4,4-Bipyridine–Squaric Acid Multicomponent Complexes with Varying Degrees of Proton Transfer: Exploring the Nature of New Form IV in the Salt Co-Crystal Continuum. Crystal Growth & Design. 2022;22(1):779 [Crossref]
2- Sharma P, Gomila R, Frontera A, Barcelo-Oliver M, Bhattacharyya M. Dicarboxylic Acid-Based Co-Crystals of Pyridine Derivatives Involving Structure Guiding Unconventional Synthons: Experimental and Theoretical Studies. Crystals. 2022;12(10):1442 [Crossref]
3- Wong S, Chen Y, Xuan B, Sun C, Chow S. Cocrystal engineering of pharmaceutical solids: therapeutic potential and challenges. CrystEngComm. 2021;23(40):7005 [Crossref]
4- Anand R, Kumar A, Nanda A. Pharmaceutical Co-Crystals - Design, Development and Applications. DDL. 2020;10(3):169 [Crossref]
5- Kiyonga E, Kekani L, Chidziwa T, Kahwenga K, Bronkhorst E, Milne M, Poka M, Mokhele S, Demana P, Witika B. Nano- and Crystal Engineering Approaches in the Development of Therapeutic Agents for Neoplastic Diseases. Crystals. 2022;12(7):926 [Crossref]
6- Bolla G, Sarma B, Nangia A. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs. Chem Rev. 2022;122(13):11514 [Crossref]
7- Rana M, Garai A, Nangia A. Cocrystals and Salts of Milrinone with Fluoro Coformers: Improving Drug Dissolution and Diffusion and Calculating Normalized Diffusion for Pharmaceutical Cocrystals. Crystal Growth & Design. 2023;23(9):6461 [Crossref]
8- Palanisamy V, Sanphui P, Jyothi V, Shastri N, Bolla G, Palanisamy K, Prakash M, Vangala V. Tuning Diffusion Permeability of an Anti-Retroviral Drug, Emtricitabine, via Multicomponent Crystallizations. Crystal Growth & Design. 2021;21(3):1548 [Crossref]
9- Nascimento A, Fernandes R, Charpentier M, ter Horst J, Caires F, Chorilli M. Co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs): Insight toward formation, methods, and drug enhancement. Particuology. 2021;58:227 [Crossref]
10- Singh M, Barua H, Jyothi V, Dhondale M, Nambiar A, Agrawal A, Kumar P, Shastri N, Kumar D. Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems. Pharmaceutics. 2023;15(4):1161 [Crossref]
11- Neelam U, Daveedu B, Ambabhai V, Siripragada M, kumar S, Balasubramanian S. Physicochemical aspects and comparative analysis of Voxelotor and its salt and cocrystal. Journal of Molecular Structure. 2023;1271:134024 [Crossref]
12- Jagia M, Kale D, Bansal A, Patel S. Novel Co-crystals and Eutectics of Febuxostat: Characterization, Mechanism of Formation, and Improved Dissolution. AAPS PharmSciTech. 2021;23(1) [Crossref]
13- Abramov Y, Wang J. Is It Salt, Cocrystal, or Continuum? Successes and Limitations of Computationally Efficient Periodic System Calculations. Crystal Growth & Design. 2024;24(10):4017 [Crossref]
14- Harfouche L, Couvrat N, Sanselme M, Brandel C, Cartigny Y, Petit S, Coquerel G. Discovery of New Proxyphylline-Based Chiral Cocrystals: Solid State Landscape and Dehydration Mechanism. Crystal Growth & Design. 2020;20(6):3842 [Crossref]
15- Patil B, Surana S, Shirkhedkar A. Co-crystallization in Antiepileptic Drugs: A Path Toward Better Therapeutic Outcomes. 2025; [Crossref]
16- Nugrahani I, Parwati R. Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development. Molecules. 2021;26(14):4185 [Crossref]
17- Kacso I, Rus L, Martin F, Miclaus M, Filip X, Dan M. Solid-state compatibility studies of Ketoconazole-Fumaric acid co-crystal with tablet excipients. J Therm Anal Calorim. 2021;143(5):3499 [Crossref]
18- Batisai E. Solubility Enhancement of Antidiabetic Drugs Using a Co‐Crystallization Approach. ChemistryOpen. 2021;10(12):1260 [Crossref]
19- Kumar A, Nanda A. In-silico methods of cocrystal screening: A review on tools for rational design of pharmaceutical cocrystals. Journal of Drug Delivery Science and Technology. 2021;63:102527 [Crossref]
20- Hassanain H, Al-Sharif S, Al-Ghamdi H, Nahari L, Al-Sulami A, Mousally S, Al-Zaydi K. Synthesis, Crystal Structure, Hirshfeld Surface Analysis, Energy Framework Calculations, and Halogen Bonding Investigation of Benzene-1,3,5-triyltris((4-chlorophenyl)methanone). Crystals. 2023;14(1):17 [Crossref]
21- Hossain Mithu M, Economidou S, Trivedi V, Bhatt S, Douroumis D. Advanced Methodologies for Pharmaceutical Salt Synthesis. Crystal Growth & Design. 2021;21(2):1358 [Crossref]
22- Bernasconi D, Bordignon S, Rossi F, Priola E, Nervi C, Gobetto R, Voinovich D, Hasa D, Duong N, Nishiyama Y, Chierotti M. Selective Synthesis of a Salt and a Cocrystal of the Ethionamide–Salicylic Acid System. Crystal Growth & Design. 2020;20(2):906 [Crossref]
23- Meng J, Qiu C, Lu C, He X, Zhao X. A new crystalline daidzein-piperazine salt with enhanced solubility, permeability, and bioavailability. Front Pharmacol. 2024;15 [Crossref]
24- An H, Choi I, Kim I. Melting Diagrams of Adefovir Dipivoxil and Dicarboxylic Acids: An Approach to Assess Cocrystal Compositions. Crystals. 2019;9(2):70 [Crossref]
25- Bal K, Collas A. Charting the salt–cocrystal continuum of acid–base multicomponent crystals with hybrid density functional theory. CrystEngComm. 2024;26(47):6765 [Crossref]
26- Nugrahani I, Fisandra F, Horikawa A, Uekusa H. New Sodium Mefenamate – Nicotinamide Multicomponent Crystal Development to Modulate Solubility and Dissolution: Preparation, Structural, and Performance Study. Journal of Pharmaceutical Sciences. 2021;110(9):3246 [Crossref]
27- Liu W, Ma R, Liang F, Duan C, Zhang G, Chen Y, Hao C. New Cocrystals of Antipsychotic Drug Aripiprazole: Decreasing the Dissolution through Cocrystallization. Molecules. 2021;26(9):2414 [Crossref]
28- Segalina A, Pavan B, Ferretti V, Spizzo F, Botti G, Bianchi A, Pastore M, Dalpiaz A. Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers. Crystal Growth & Design. 2022;22(5):3090 [Crossref]
29- Saikia B, Pathak D, Sarma B. Variable stoichiometry cocrystals: occurrence and significance. CrystEngComm. 2021;23(26):4583 [Crossref]
30- Kenguva G, Giri L, Rout S, Acharya A, Dandela R. Exploration of different solid variants of the anticancer medication Panobinostat (PNB) with improved physicochemical attributes. Journal of Molecular Structure. 2023;1292:136086 [Crossref]
31- Selivanova I, Terekhov R. Crystal engineering as a scientific basis for modification of physicochemical properties of bioflavonoids. Russ Chem Bull. 2019;68(12):2155 [Crossref]
32- SARAF G, BURADE K, GONJARI I, HOSMANI A, PAWAR A. A REVIEW ON ADVANCES IN PHARMACEUTICAL CO-CRYSTAL PREPARATION ROUTES, INTELLECTUAL PROPERTY PERSPECTIVE AND REGULATORY ASPECTS. Int J Curr Pharm Sci. 2022;:4 [Crossref]
33- Garg U, Azim Y. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs. RSC Med Chem. 2021;12(5):705 [Crossref]
34- Pindelska E, Sarna A, Duszczyk M, Zep A, Madura I. Enhancing Febuxostat Solubility Through Cocrystal Formation: Role of Substrate Selection and Amide Coformers. IJMS. 2025;26(7):3004 [Crossref]
35- Ganesan T, Muthudoss P, Voguri R, Ghosal S, Ann E, Kwok J, Shahnawaz S, Omar M, Allada R, See H. A new Febuxostat-Telmisartan Drug-Drug Cocrystal for Gout-Hypertension Combination Therapy. Journal of Pharmaceutical Sciences. 2022;111(12):3318 [Crossref]
36- Braga D. Crystal engineering: from promise to delivery. Chem Commun. 2023;59(95):14052 [Crossref]
37- Garbacz P, Paukszta D, Sikorski A, Wesolowski M. Structural Characterization of Co-Crystals of Chlordiazepoxide with p-Aminobenzoic Acid and Lorazepam with Nicotinamide by DSC, X-ray Diffraction, FTIR and Raman Spectroscopy. Pharmaceutics. 2020;12(7):648 [Crossref]
38- Feliciano I, Silva D, Piedade M, Bernardes C, Minas da Piedade M. First and Second Dissociation Enthalpies in Bi-Component Crystals Consisting of Maleic Acid and L-Phenylalanine. Molecules. 2021;26(18):5714 [Crossref]
39- Diniz L, Carvalho P, Souza M, Diniz R, Fernandes C. Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation. Mol Pharmaceutics. 2024;21(7):3661 [Crossref]
40- Kumbhar P, Kolekar K, Khot C, Dabhole S, Salawi A, Sabei F, Mohite A, Kole K, Mhatre S, Jha N, Manjappa A, Singh S, Dua K, Disouza J, Patravale V. Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications. Journal of Controlled Release. 2023;353:1150 [Crossref]
41- Radek Štoček J, Blahut J, Chalupná S, Čejka J, Štěpánová S, Kašička V, Hušák M, Dračínský M. The Hydrogen‐Bond Continuum in the Salt/Cocrystal Systems of Quinoline and Chloro‐Nitrobenzoic Acids. Chemistry A European J. 2024;30(68) [Crossref]
42- Dračínský M. Analyzing Discrepancies in Chemical-Shift Predictions of Solid Pyridinium Fumarates. Molecules. 2021;26(13):3857 [Crossref]
43- De Silva V, Averkiev B, Sinha A, Aakeröy C. The Balance between Hydrogen Bonds, Halogen Bonds, and Chalcogen Bonds in the Crystal Structures of a Series of 1,3,4-Chalcogenadiazoles. Molecules. 2021;26(14):4125 [Crossref]
44- Al-Kazemi R, Al-Basarah Y, Nada A. Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization. Adv Pharm Bull. 2019;9(4):559 [Crossref]
45- Acebedo-Martínez F, Alarcón-Payer C, Rodríguez-Domingo L, Domínguez-Martín A, Gómez-Morales J, Choquesillo-Lazarte D. Furosemide/Non-Steroidal Anti-Inflammatory Drug–Drug Pharmaceutical Solids: Novel Opportunities in Drug Formulation. Crystals. 2021;11(11):1339 [Crossref]
46- Chauhan V, Mardia R, Patel M, Suhagia B, Parmar K. Technical and Formulation Aspects of Pharmaceutical Co‐Crystallization: A Systematic Review. ChemistrySelect. 2022;7(37) [Crossref]
47- Xia M, Zhu B, Wang J, Yang Z, Mei X. Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues. ACS Med Chem Lett. 2022;13(1):29 [Crossref]
48- Verma P, Srivastava A, Tandon P, Shimpi M. Insights into structural, spectroscopic, and hydrogen bonding interaction patterns of nicotinamide–oxalic acid (form I) salt by using experimental and theoretical approaches. Front Chem. 2023;11 [Crossref]
49- Banerjee M, Nimkar K, Naik S, Patravale V. Unlocking the potential of drug-drug cocrystals – A comprehensive review. Journal of Controlled Release. 2022;348:456 [Crossref]
50- Elshaer M, Osman S, Mohammed A, Zayed G. Co-crystallization of Hesperidin with different co-formers to enhance solubility, antioxidant and anti-inflammatory activities. Pharmaceutical Development and Technology. 2024;29(7):691 [Crossref]
51- Long B, Verma V, Ryan K, Padrela L. Generation and physicochemical characterization of posaconazole cocrystals using Gas Antisolvent (GAS) and Supercritical Solvent (CSS) methods. The Journal of Supercritical Fluids. 2021;170:105134 [Crossref]
52- Štoček J, Socha O, Císařová I, Slanina T, Dračínský M. Importance of Nuclear Quantum Effects for Molecular Cocrystals with Short Hydrogen Bonds. J Am Chem Soc. 2022;144(16):7111 [Crossref]
53- Zochedh A, Chandran K, Shunmuganarayanan A, Sultan A. Exploring the Synergistic Effect of Tegafur-Syringic Acid Adduct Against Breast Cancer through DFT Computation, Spectroscopy, Pharmacokinetics and Molecular Docking Simulation. Polycyclic Aromatic Compounds. 2024;44(4):2153 [Crossref]